Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: Association with disease activity and outcome parameters

Rheumatology International

Volumn 32, Issue 12, 2012, Pages 3765-3770

  Konca, Şefika ^a   Keskin, Dilek ^a   Cılız, Deniz ^a   Bodur, Hatice ^a   Sakman, Bülent ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Ankylosing spondylitis; Disease activity; Magnetic resonance imaging; Spinal inflammation

Indexed keywords

C REACTIVE PROTEIN; SALAZOSULFAPYRIDINE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; BATH ANKYLOSING SPONDYLITIS METROLOGY INDEX; BATH ANKYLOSING SPONDYLITIS RADIOLOGY INDEX; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LABORATORY TEST; MALE; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 84872270182     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2248-5     Document Type: Article

References (27)

1. Gensler L (2011) Clinical features of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 5th edn. Mosby Elsevier, Philadelphia, pp 1129-1134
2. Braun J, Rudwaleit M, Hermann KG, Rau R (2007) Imaging in ankylosing spondylitis. Z Rheumatol 66:167-178
3. Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J, Bollow M, Sieper J, Van Der Heijde D (2003) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system. Arthritis Rheum 48:1126-1136
4. Wendling D, Toussirot E, Streit G, Prati C (2006) Imaging study scores for ankylosing spondylitis. Jt Bone Spine 73:655-660
5. Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria? Arthritis Rheum 52:1000-1008
6. Baraliakos X, Davis J, Tsuji W, Braun J (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 52:1216-1223
7. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J (2009) The Assessment of Spondylo Arthritis International Society (ASAS) handbook: A guide to assess spondyloarthritis. Ann Rheum Dis 68:1-44
8. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: Reliability and validity. Rheumatol Int 25:280-284
9. Yanik B, Gursel YK, Kutlay S, Ay S, Elhan AH (2005) Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: Functional assessment in AS. Clin Rheumatol 24:41-47
10. Jenkinson TR, Mallorie PA, Whitelock HC (1994) Defining spinal mobility in ankylosing spondylitis (AS): The Bath AS Metrology Index. J Rheumatol 21:694-698
11. Madsen OR, Hansen LB, Rytter A, Suetta C, Egsmose C (2009) The bath metrology index as assessed by a trained and an untrained rater in patients with spondyloarthropathy: A study of intra-and inter-rater agreements. Clin Rheumatol 28:35-40
12. MacKay K, Mack C, Brophy S, Calin A (1998) The Bath Ankylosing Spondylitis Radiology Index (BASRI): A new, validated approach to disease assessment. Arthritis Rheum 41:2263-2270
13. Tuncay Duruoz LD, Cerrahoglu L, Turan Y, Sari H (2008) Translation and validation of the Turkish version of the ankylosing spondylitis quality of life (ASQOL) questionnaire. Ann Rheum Dis 67(Suppl II):623
14. Lukas C, Landewé R, Sieper J (2009) Development of an ASASendorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68:18-24
15. Van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewé R, Assessment of Spondylo Arthritis international Society (ASAS) (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811-1818
16. Lukas C, Braun J, van der Heijde D, Hermann KG, Rudwaleit M, Østergaard M, Oostveen A, O'Connor P, Maksymowych WP, Lambert RG, Jurik AG, Baraliakos X, Landewé R (2007) Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: A multireader experiment. ASAS/OMERACT MRI in AS Working Group. J Rheumatol 34: 862-870
17. Heikkila S, Viitanen JV, Kautiainen H, Kauppi M (2002) Functional long-term changes in patients with spondyloarthropathy. Clin Rheumatol 21:119-122
18. Akdeniz O, Alayli G, Tosun FC, Diren B, Cengiz K, Selçuk MB, Sunter T, Canturk F (2008) Early spondyloarthropaty: Scintigraphic, biological, and clinical findings in MR-positive patients. Clin Rheumatol 27:469-474
19. Baraliakos X, Davis J, Tsuji W, Braun J (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 52:1216-1223
20. Baraliakos X, Hermann KG, Landewé R, Listing J, Golder W, Brandt J, Rudwailet M, Bollow M, Sieper J, van der Heijde D, Braun J (2005) Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: A comparison contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis 64:1141-1144
21. van der Heijde D, Landewé R (2005) Imaging in spondylitis. Curr Opin Rheumatol 17:413-417
22. Braun J, Baraliakos X, Golder W, Hermann KG, Listing J, Brandt J, Rudwaleit M, Zuehlsdorf S, Bollow M, Sieper J, van der Heijde D (2004) Analysing chronic spinal changes in ankylosing spondylitis: A systematic comparison of conventional X rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis 63:1046-1055
23. Sieper J, Baraliakos X, Listing J, Brandt J, Haibel H, Rudwailet M, Braun J (2005) Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab. Rheumatology 44:1525-1530
24. Baraliakos X, Landewe R, Hermann KG, Listing J, Golder W, Brandt J, Rudwaleit M, Bollow M, Sieper J, van der Heijde D, Braun J (2005) Inflammation in ankylosing spondylitis: A systematic description of the extension and frequency of acute spinal changes using magnetic resonance imaging (MRI). Ann Rheum Dis 64:730-734
25. Pedersen SJ, Sørensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Johansen JS, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Hansen A, Ostergaard M (2010) Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 69:1065-1071
26. Romero-Sánchez C, Robinson WH, Tomooka BH, Londono J, Valle-Onate R, Huang F, Deng X, Zhang L, Yang C, Yu DT (2008) Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis. Clin Rheumatol 27:1429-1435
27. Puhakka KB, Jurik AG, Schiottz-Christensen B, Magnetic resonance imaging of sacroiliitis in early seronegative spondyloarthropathy et al (2004) Abnormalities correlated to clinical and laboratory findings. Rheumatology (Oxford) 43:234-237